These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 2369725)
1. Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence. Milas L; Furuta Y; Hunter N; Nishiguchi I; Runkel S Cancer Res; 1990 Aug; 50(15):4473-7. PubMed ID: 2369725 [TBL] [Abstract][Full Text] [Related]
2. Increase in radioresponse of murine tumors by treatment with indomethacin. Furuta Y; Hunter N; Barkley T; Hall E; Milas L Cancer Res; 1988 Jun; 48(11):3008-13. PubMed ID: 3365690 [TBL] [Abstract][Full Text] [Related]
3. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Kishi K; Petersen S; Petersen C; Hunter N; Mason K; Masferrer JL; Tofilon PJ; Milas L Cancer Res; 2000 Mar; 60(5):1326-31. PubMed ID: 10728694 [TBL] [Abstract][Full Text] [Related]
4. CpG oligodeoxynucleotide enhances tumor response to radiation. Milas L; Mason KA; Ariga H; Hunter N; Neal R; Valdecanas D; Krieg AM; Whisnant JK Cancer Res; 2004 Aug; 64(15):5074-7. PubMed ID: 15289307 [TBL] [Abstract][Full Text] [Related]
6. Improvement in therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus misonidazole. Milas L; Ito H; Nakayama T; Hunter N Cancer Res; 1991 Jul; 51(14):3639-42. PubMed ID: 2065321 [TBL] [Abstract][Full Text] [Related]
7. Improvement in radiotherapy for a murine sarcoma by indomethacin plus WR-2721. Besa PC; Hunter NR; Milas L Radiat Res; 1993 Jul; 135(1):93-7. PubMed ID: 8392213 [TBL] [Abstract][Full Text] [Related]
8. Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin. Furuta Y; Hall ER; Sanduja S; Barkley T; Milas L Cancer Res; 1988 Jun; 48(11):3002-7. PubMed ID: 3130182 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response. Griffin RJ; Williams BW; Wild R; Cherrington JM; Park H; Song CW Cancer Res; 2002 Mar; 62(6):1702-6. PubMed ID: 11912143 [TBL] [Abstract][Full Text] [Related]
10. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy. Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567 [TBL] [Abstract][Full Text] [Related]
11. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance. Milas L; McBride WH; Hunter N; Ito H Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014 [TBL] [Abstract][Full Text] [Related]
12. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy. Urano M; Kuroda M; Reynolds R; Oberley TD; St Clair DK Cancer Res; 1995 Jun; 55(12):2490-3. PubMed ID: 7780953 [TBL] [Abstract][Full Text] [Related]
13. Erbulozole (P.I.N.N.) (R 55 104) encapsulated into cyclodextrins: has it a combined antitumoral and radioprotective potential? Distelmans W; Van Ginckel R; Vanherck W; Willebrords R; Wouters L; De Brabander M; Mesens J Anticancer Res; 1991; 11(1):253-6. PubMed ID: 2018359 [TBL] [Abstract][Full Text] [Related]
19. The prostaglandin E1 analog, misoprostol, a normal tissue protector, does not protect four murine tumors in vivo from radiation injury. Hanson WR; Zhen W; Geng L; Hunter N; Milas L Radiat Res; 1995 Jun; 142(3):281-7. PubMed ID: 7761578 [TBL] [Abstract][Full Text] [Related]
20. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse. Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]